Bliss GVS Pharma Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 1,58,050 shares,. Its Average Traded Price (ATP) is ₹633.08, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 10 @ ₹623.35.
Bliss GVS Pharma has an upper circuit limit of ₹654.50 and a lower circuit limit of ₹592.20. The total value traded stands at ₹10.01 CR, and the delivery percentage for the day is 0%.
The stock is currently traded with a market lot size of 1. Bliss GVS Pharma also offers a dividend yield of 0.24%.
Bliss GVS Pharma Share Price Chart
Bliss GVS Pharma Share Key Metrics
Volume
1.58 L
Market Cap
6624.67 CR
LTQ@LTP
10@623.35
ATP
633.08
Var Margin
100 %
Circuit Range
592.2-654.5
Delivery %
0 %
Value
10.01 CR
ASM/GSM
No
Market Lot
1
Bliss GVS Pharma Resistance and Support
Pivot 628.13
Resistance
First Resistance
657.26
Second Resistance
671.83
Third Resistance
700.96
Support
First Support
613.56
Second Support
584.43
Third Support
569.86
Bliss GVS Pharma Shareholding Pattern
View More- 2016-17
- 2017-18
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Bliss GVS Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-10-01 | Employees Stock Option Plan |
| 2026-08-12 | Quarterly Results |
Bliss GVS Pharma News
Bliss GVS Pharma Ltd - 506197 - Board Meeting Intimation for To Consider And Approve, Inter Alia, The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2026.
Bliss GVS Pharma's board of directors is scheduled to meet on October 29, 2026. The meeting will focus on approving the financial results for the quarter and half year ended September 30, 2026.
Oct 22 2026 20:11:18
Bliss GVS Pharma Ltd - 506197 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Bliss GVS has issued a postal ballot notice for the appointment of three Non-Executive Non-Independent Directors nominated by its new promoters. The e-voting window will close on November 14, 2026.
Oct 15 2026 18:22:22
Bliss GVS Pharma Ltd - 506197 - Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations")
Anupam Rasayan India and Mates Visa Consultancy have acquired control of Bliss GVS Pharma following the completion of their open offer. The new entities have been classified as Promoters, while erstwhile promoters are now reclassified as Public.
Oct 14 2026 18:40:44
Bliss GVS Pharma Ltd - 506197 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
Catalyst Trusteeship Limited disclosed the creation of a pledge over 5,09,84,595 equity shares of Bliss GVS Pharma, representing a 47.95% stake. The pledge was created on September 30, 2026, acting as a debenture trustee.
Oct 06 2026 10:26:09
Bliss GVS Pharma Ltd - 506197 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
Anupam Rasayan India and its PAC acquired 5,09,84,595 shares, representing a 47.95% stake in Bliss GVS Pharma, on 28 September 2026. This acquisition brings their total combined holding to 50.07%, triggering a change in control and establishing them as the new promoters.
Oct 01 2026 09:01:24
Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Meeting Updates
Bliss GVS Pharma board noted the reclassification of outgoing promoters to the public category. Their aggregate shareholding dropped from 34.82% to 0.01% following the completion of a share transfer and open offer by Anupam Rasayan India Ltd, which has now acquired control of the company.
Sep 28 2026 20:53:08
Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Meeting Updates
Anupam Rasayan India Ltd and Mates Visa Consultancy Pvt Ltd have completed the acquisition of a 47.95% stake in Bliss GVS Pharma, officially becoming the new promoters. Following the change in control, Narsimha Shibroor Kamath has resigned as Managing Director, and three new non-independent directors were appointed.
Sep 28 2026 20:48:44
Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Change in Management Control
Anupam Rasayan India Ltd and its PAC have acquired control of Bliss GVS Pharma Ltd, holding a 47.95% stake post the completion of an Open Offer. Consequently, MD Narsimha Shibroor Kamath has resigned and three new directors have been appointed.
Sep 28 2026 20:32:28
Bliss GVS Pharma Management
| Name | Position |
|---|---|
| Aditi Bhatt | Company Secretary & Compliance Officer |
| Nandkumar chodankar | Chairman |
Bliss GVS Pharma Similar Stocks
Suven Life Sciences Ltd.
261.35
-6.85 (2.55%)
Symbiotec Pharmalab Ltd.
1164.20
-33.30 (2.78%)
Aarti Pharmalabs Ltd.
820.85
-7.95 (0.96%)
Thyrocare Technologies Ltd.
463.15
-8.95 (1.90%)
Sanofi India Ltd.
2772.80
-58.30 (2.06%)
Kovai Medical Center & Hospital Ltd.
5757.50
-49.00 (0.84%)
Morepen Laboratories Ltd.
123.54
5.87 (4.99%)
Nephrocare Health Services Ltd.
596.45
-5.95 (0.99%)
Senores Pharmaceuticals Ltd.
1215.30
12.70 (1.06%)
Bliss GVS Pharma FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in BLISSGVS
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
+ Free 1st Year AMC